Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20Sexual Dysfunctions, Psychological 1Polycystic Ovary Syndrome 1Neoplasm Metastasis 1Hot Flashes 1Hormone Receptor Positive Breast Carcinoma 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1Endometrial Stromal Tumors 1Carcinoma, Intraductal, Noninfiltrating 1Arthralgia 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Breast Cancer 1

Interventions

Metformin 21Inositol 14Letrozole 9Exercise 5Surveys and Questionnaires 4Clomiphene 4Tablets 3Estradiol 3semaglutide 2maltodextrin 2drospirenone and ethinyl estradiol combination 2Spironolactone 2Progesterone 2Ethinyl Estradiol 2Diet Therapy 2Contraceptives, Oral, Combined 2Caloric Restriction 2Acupuncture Therapy 2mirabegron 1etonogestrel 1drospirenone 1dapagliflozin 1cetrorelix 1Walking 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Tamoxifen 1Sodium-Glucose Transporter 2 Inhibitors 1Sex Characteristics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Aromatase Inhibitors × 1 year × Clear all
NCT07379502 2026-01-30

Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate

CMH Kharian Medical College

Phase NA Not yet recruiting
60 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡